CH415631A - Verfahren zur Herstellung von a-(3-Indolyl)-niedrigaliphatischen-säuren - Google Patents
Verfahren zur Herstellung von a-(3-Indolyl)-niedrigaliphatischen-säurenInfo
- Publication number
- CH415631A CH415631A CH983860A CH983860A CH415631A CH 415631 A CH415631 A CH 415631A CH 983860 A CH983860 A CH 983860A CH 983860 A CH983860 A CH 983860A CH 415631 A CH415631 A CH 415631A
- Authority
- CH
- Switzerland
- Prior art keywords
- indolyl
- acids
- preparation
- lower aliphatic
- aliphatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83777459A | 1959-09-03 | 1959-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH415631A true CH415631A (de) | 1966-06-30 |
Family
ID=25275378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH983860A CH415631A (de) | 1959-09-03 | 1960-08-31 | Verfahren zur Herstellung von a-(3-Indolyl)-niedrigaliphatischen-säuren |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE594596A (fr) |
| CH (1) | CH415631A (fr) |
| ES (1) | ES260797A1 (fr) |
| GB (1) | GB948460A (fr) |
| NO (1) | NO116545B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB957990A (en) * | 1961-03-14 | 1964-05-13 | Merck & Co Inc | Salts of substituted indoles |
| US5081145A (en) * | 1990-02-01 | 1992-01-14 | Merck Frosst Canada, Inc. | Indole-2-alkanoic acids compositions of and anti allergic use thereof |
| US5510368A (en) * | 1995-05-22 | 1996-04-23 | Merck Frosst Canada, Inc. | N-benzyl-3-indoleacetic acids as antiinflammatory drugs |
-
1960
- 1960-08-30 GB GB29839/60A patent/GB948460A/en not_active Expired
- 1960-08-31 BE BE594596A patent/BE594596A/fr unknown
- 1960-08-31 CH CH983860A patent/CH415631A/de unknown
- 1960-09-02 NO NO149593A patent/NO116545B/no unknown
- 1960-09-03 ES ES0260797A patent/ES260797A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE594596A (fr) | 1961-02-28 |
| ES260797A1 (es) | 1961-04-01 |
| NO116545B (fr) | 1969-04-14 |
| GB948460A (en) | 1964-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH370197A (de) | Verfahren zur Herstellung von Actinospectacin | |
| CH387047A (de) | Verfahren zur Herstellung von Ketosidopurinen | |
| CH400144A (de) | Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten | |
| CH419127A (de) | Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen | |
| CH426822A (de) | Verfahren zur Herstellung von a-(3-Indolyl)-niederaliphatischen-säuren | |
| CH404962A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH396026A (de) | Verfahren zur Herstellung von Halogenalkylaminen | |
| CH415631A (de) | Verfahren zur Herstellung von a-(3-Indolyl)-niedrigaliphatischen-säuren | |
| CH387606A (de) | Verfahren zur Herstellung von Tetrahydroxydibor | |
| CH399742A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH387029A (de) | Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron | |
| CH440249A (de) | Verfahren zur Herstellung von Polychlorbenzonitrilen | |
| CH408916A (de) | Verfahren zur Herstellung von a-(1-Benzyl-3-indolyl)-niedrig-aliphatischen Säuren | |
| CH417595A (de) | Verfahren zur Herstellung von Alkyl-5-alkylisoxazol-3-carboxylaten | |
| CH538458A (de) | Verfahren zur Herstellung von a-Dithiosemicarbazonen | |
| CH372297A (de) | Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden | |
| CH416113A (de) | Verfahren zur Herstellung von Eupolyoxymethylenen | |
| CH395992A (de) | Verfahren zur Herstellung von 1-(o-Tolyloxyäthyl)-4-phenyl-piperidin | |
| CH378344A (de) | Verfahren zur Herstellung von 2-Amino-anthrachinonen | |
| CH412841A (de) | Verfahren zur Herstellung von 2-Trifluormethylbenzophenon | |
| AT221092B (de) | Verfahren zur Herstellung von substituierten 2-Oxo-benzochinolizinen | |
| CH385849A (de) | Verfahren zur Herstellung von substituierten 2-Oxobenzochinolizinen | |
| AT221096B (de) | Verfahren zur Herstellung von 2-Hydrazino-3-mercapto-chinoxalin | |
| AT221103B (de) | Verfahren zur Herstellung von Monoalkylphosphinen | |
| AT221494B (de) | Verfahren zur Herstellung von α-Amino-ω-lactamen |